Mammalian Cell-Based Enzyme Expression Services

Background: The Strategic Importance of Mammalian Cell Systems in Recombinant Enzyme Production

Recombinant enzyme production has evolved significantly over the past decades, with various host systems—including bacteria, yeast, insect cells, and mammalian cells—serving distinct research and industrial needs. While microbial systems offer speed and cost efficiency, they often lack the cellular machinery necessary for complex post-translational modifications (PTMs) such as human-like glycosylation, accurate disulfide bond formation, and regulated proteolytic processing.

Mammalian cell-based expression systems, particularly Chinese Hamster Ovary (CHO) cells and Human Embryonic Kidney 293 (HEK293) cells, provide an intracellular environment that closely resembles native human physiology. This enables the production of enzymes with correct tertiary and quaternary structures, appropriate glycosylation patterns, and full biological activity.

For therapeutic enzymes, glycosyltransferases, proteases, kinases, and other clinically relevant proteins, structural fidelity is not merely advantageous—it is essential. Subtle variations in glycan composition can significantly influence enzyme stability, pharmacokinetics, immunogenicity, and receptor interactions. As regulatory expectations continue to rise in the biopharmaceutical sector, mammalian expression platforms have become increasingly critical for generating enzymes suitable for translational research and therapeutic development.

Creative Enzymes has developed robust mammalian cell-based expression capabilities to address these growing demands, offering scalable, reproducible, and application-specific enzyme production solutions.

What We Offer: Comprehensive Mammalian Cell-Based Enzyme Expression Solutions

Creative Enzymes delivers fully integrated services covering the entire enzyme production lifecycle. Our offerings include:

Our services are designed to accommodate diverse enzyme classes, including secreted hydrolases, oxidoreductases, transferases, proteases, kinases, glycosidases, and membrane-associated enzymes.

Service Workflow

Contact Our Team

Why Choose Creative Enzymes for Mammalian Cell-Based Enzyme Expression

Case Studies: Practical Applications of Mammalian Cell-Based Enzyme Expression

Frequently Asked Questions (FAQs) on Mammalian Cell-Based Enzyme Expression Services

• Q: When should I choose mammalian expression over bacterial or yeast systems?

  A: Mammalian expression is recommended when your enzyme requires complex post-translational modifications, correct glycosylation, precise disulfide bond formation, or native-like folding. Therapeutic enzymes and glycoproteins particularly benefit from mammalian systems.

• Q: Can you scale production beyond research quantities?

  A: Yes. Our mammalian cell platforms support scale-up to pilot-scale bioreactor production. We design processes that maintain product consistency during scale transitions.

• Q: Do you provide glycosylation analysis?

  A: Yes. We offer glycan profiling using HPLC and mass spectrometry to confirm N- and O-linked glycosylation patterns, ensuring suitability for therapeutic or diagnostic use.

• Q: How do you ensure enzyme activity?

  A: Each enzyme undergoes functional validation using substrate-specific assays. Kinetic parameters such as K_m and V_max can be determined upon request.

• Q: Can you express membrane-bound enzymes?

  A: Yes. We have experience expressing membrane-associated and transmembrane enzymes using optimized signal sequences and solubilization protocols.

• Q: Is the service customizable for specialized requirements?

  A: Absolutely. We tailor vector design, cell line selection, purification strategies, and analytical methods according to client objectives.